Where to Inject Tirzepatide: The Three Label Sites, Rotation, Pen vs KwikPen vs Vial, and What to Do When It Goes Wrong

Written by Nataliia Bondarchuk. Updated October 27, 2026.

Tirzepatide is injected under the skin in one of three places: the stomach, at least two inches from the navel; the front of the thigh; or the back of the upper arm, which usually needs someone else to do it. All three absorb the drug equally well, so the choice comes down to what you can reach, what hurts least and where you injected last week, because the one rule that matters more than the site itself is rotation. Inject into the same spot every week and you get lumps, bruising and patchy absorption; move an inch or two each time and you get none of those.

This guide covers the three label sites and how to choose between them, a rotation plan, the differences between the Zepbound and Mounjaro autoinjector pen, the newer KwikPen and the vial-and-syringe option, step by step, and what to do when something goes wrong: a leak, blood, a pen that did not click, or a shot that went into muscle.

In pharmacokinetic studies of tirzepatide the exposure from the abdomen, thigh and arm was equivalent, which is why the label lists all three without preference. The pain difference is small and individual; the abdomen tends to win in surveys because it has the most subcutaneous fat and the fewest nerve endings per square inch.

Injecting the same spot repeatedly causes lipohypertrophy, a rubbery lump of fat tissue that is slow to absorb drug, and bruising that makes the next injection worse. The label's instruction is to change the site each week, and the simplest way to do that is to make it a calendar. One pattern: four weeks on the abdomen, moving clockwise around the navel like a clock face, left upper, right upper, right lower, left lower, each at least an inch from the last; then four weeks on the thighs, alternating left and right; then back. Another: abdomen one week, left thigh the next, right thigh the next, repeat. Note it in the phone calendar with the dose; after a few months it is impossible to remember otherwise. If you find a lump, do not inject into or near it; it will shrink over weeks if left alone.

Tirzepatide comes in three devices in the US, and the steps differ enough that people switching between them make mistakes. The original Zepbound and Mounjaro pen is a single-dose autoinjector with a hidden needle: unlock, press, hold for ten seconds, done, pen in the sharps bin. The Zepbound KwikPen, launched in February 2026, holds four weekly doses, uses a separate pen needle attached each time, and requires a priming step before the first use; it is the device behind the lower self-pay prices. Zepbound single-dose vials, sold through LillyDirect, require drawing the dose into a syringe yourself. The injection sites and rotation are identical for all three; what changes is the needle, the priming and the number of steps.

The KwikPen's priming, dialing and storage rules are covered in detail in the Zepbound KwikPen guide. Which dose you are on, and the escalation schedule, is in tirzepatide dosage for weight loss. Mounjaro and Zepbound are the same drug in the same autoinjector; the difference is the indication, as explained in Mounjaro vs Zepbound.

For the drug, it makes no difference; the blood levels are the same. For you, the stomach usually wins on comfort and the thigh wins on convenience and visibility, and the right answer is both, alternated. Two situations tilt the choice. People who are very lean, which becomes more people as treatment goes on, have less fat on the thigh and can find the needle reaches muscle there; the abdomen keeps its subcutaneous layer longer. People with a sensitive or scarred abdomen, from surgery or pregnancy, do better on the thigh. Neither site affects nausea, which comes from the drug's action on the gut and brain rather than from where it enters; see how Zepbound works.

No, on both counts, provided the drug goes under the skin. The weight-loss trajectory in tirzepatide weight loss by week applies to any of the three sites, and if the scale has stalled the injection site is not on the list of reasons in why am I not losing weight on tirzepatide, unless lumps from poor rotation are interfering with absorption. The nausea, constipation and fatigue of the first weeks come from the drug itself; the foods that make them better or worse are in best foods to eat on tirzepatide, and the full side-effect list is on our tirzepatide side effects page. What the site does affect is the local reaction: redness, itching and a small bump at the injection point were reported by about 3% of trial participants, and almost all of them had been injecting the same area.

Inject tirzepatide into the abdomen two inches from the navel, the front or outer thigh, or the back of the upper arm; all three work equally well. Rotate every week, moving at least an inch, and never into bruised, scarred or lumpy skin. Match your steps to the device you have: a single-dose autoinjector needs no dialing or priming, the KwikPen needs both and a new needle each time, and a vial needs a syringe and a steady hand. A warm pen, a dry site and a full ten-second hold take care of most of the rest.

This article summarizes the manufacturer's instructions for general information. Follow the instructions for use supplied with your device and ask your pharmacist to demonstrate the first injection.